Background: Chronic kidney disease (CKD) patients who live far (>30 miles) from their nephrologist experience lower rates of clinic visit adherence, limited access to treatment, and higher rates of hospitalization and mortality than patients who live in close proximity to their nephrologist. Strategies to minimize disparities between urban and remotely located CKD patients are needed. The purpose of this study was to determine whether adherence to clinic visits and clinical outcomes in the remote management of CKD via telenephrology is comparable to in-person conventional care. Methods: Renal clinic adherence and composite outcomes of death, end-stage renal disease (ESRD), or doubling of serum creatinine (Cr) were measured in geographically remote Hudson Valley VA Medical Center (HVVAMC) CKD patients enrolled in telenephrology (n = 112) and CKD patients enrolled in the Bronx VAMC renal clinic (n = 116). Results: Prior to implementing the telenephrology service, 53.1% of scheduled visits of rural HVVAMC patients to the Bronx VAMC renal clinic were either cancelled or were “no-shows.” This was reduced by nearly half (28.5%) after instituting telenephrology (p < 0.001). Moreover, the frequency of attending appointments was greater in the telenephrology (71.9%) vs. in-person Bronx VA cohort (61.0%). The incidence of the composite outcome of death, ESRD, or doubling of Cr was similar between both groups (p = 0.96) over 2 years of follow-up. Conclusions: Remote CKD care delivered through telenephrology improves renal clinic visit adherence while delivering comparable renal outcomes. Application of this technology is a promising method to provide access to care to rural CKD patients and to minimize the disparity between urban/rural patients.

Keywords:
Chronic kidney disease, Telemedicine, Remote care, Rural, Clinic adherence
1.
Tozawa M, Iseki K, Iseki C, Oshiro S, Ikemiya Y, Takishita S: Influence of smoking and obesity on the development of proteinuria. Kidney Int 2002; 62: 956–962.
2.
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038–2047.
3.
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(2 suppl 1):S1–S266.
4.
Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP: Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol 2001; 12: 1713–1720.
5.
Bello AK, Hemmelgarn B, Lin M, Manns B, Klarenbach S, Thompson S, James M, Tonelli M; Alberta Kidney Disease Network: Impact of remote location on quality care delivery and relationships to adverse health outcomes in patients with diabetes and chronic kidney disease. Nephrol Dial Transplant 2012; 27: 3849–3855.
6.
Rucker D, Hemmelgarn BR, Lin M, Manns BJ, Klarenbach SW, Ayyalasomayajula B, James MT, Bello A, Gordon D, Jindal KK, et al: Quality of care and mortality are worse in chronic kidney disease patients living in remote areas. Kidney Int 2011; 79: 210–217.
7.
Narva AS, Romancito G, Faber T, Steele ME, Kempner KM: Managing CKD by Telemedicine: The Zuni Telenephrology Clinic. Adv Chronic Kidney Dis 2017; 24: 6–11.
8.
Rasmussen BS, Froekjaer J, Bjerregaard MR, Lauritsen J, Hangaard J, Henriksen CW, Halekoh U, Yderstraede KB: A randomized controlled trial comparing telemedical and standard outpatient monitoring of diabetic foot ulcers. Diabetes care 2015; 38: 1723–1729.
9.
Omboni S, Ferrari R: The role of telemedicine in hypertension management: focus on blood pressure telemonitoring. Curr Hypertens Rep 2015; 17: 535.
10.
Mansberger SL, Sheppler C, Barker G, Gardiner SK, Demirel S, Wooten K, Becker TM: Long-term comparative effectiveness of telemedicine in providing diabetic retinopathy screening examinations: a randomized clinical trial. JAMA ophthalmol 2015; 133: 518–525.
11.
Zhai YK, Zhu WJ, Cai YL, Sun DX, Zhao J: Clinical- and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis. Medicine (Baltimore) 2014; 93:e312.
12.
Silva GS, Farrell S, Shandra E, Viswanathan A, Schwamm LH: The status of telestroke in the United States: a survey of currently active stroke telemedicine programs. Stroke 2012; 43: 2078–2085.
13.
Dimmick SL, Burgiss SG, Robbins S, Black D, Jarnagin B, Anders M: Outcomes of an integrated telehealth network demonstration project. Telemed J E Health 2003; 9: 13–23.
14.
Arora S, Thornton K, Murata G, Deming P, Kalishman S, Dion D, Parish B, Burke T, Pak W, Dunkelberg J, et al: Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011; 364: 2199–2207.
15.
Ishani A, Christopher J, Palmer D, Otterness S, Clothier B, Nugent S, Nelson D, Rosenberg ME; Center for Innovative Kidney Care: Telehealth by an interprofessional team in patients with CKD: a randomized controlled trial. Am J Kidney Dis 2016; 68: 41–49.
16.
Kinchen KS, Sadler J, Fink N, Brookmeyer R, Klag MJ, Levey AS, Powe NR: The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 2002; 137: 479–486.
17.
Raithatha A, McKane W, Kendray D, Evans C: Catheter access for hemodialysis defines higher mortality in late-presenting dialysis patients. Ren Fail 2010; 32: 1183–1188.
18.
Shin SJ, Kim HW, Chung S, Chung HW, Lee SJ, Kim YS, Bang BK, Chang YS, Park CW: Late referral to a nephrologist increases the risk of uremia-related cardiac hypertrophy in patients on hemodialysis. Nephron Clin Pract 2007; 107:c139–c146.
19.
Dogan E, Erkoc R, Sayarlioglu H, Durmus A, Topal C: Effects of late referral to a nephrologist in patients with chronic renal failure. Nephrology (Carlton) 2005; 10: 516–519.
20.
Goransson LG, Bergrem H: Consequences of late referral of patients with end-stage renal disease. J Intern Med 2001; 250: 154–159.
21.
Rodriguez RA: Dialysis and mortality: does it matter where you live? Clin J Am Soc Nephrol 2012; 7: 1055–1057.
22.
Maripuri S, Arbogast P, Ikizler TA, Cavanaugh KL: Rural and micropolitan residence and mortality in patients on dialysis. Clin J Am Soc Nephrol 2012; 7: 1121–1129.
23.
Magnus M, Sikka N, Cherian T, Lew SQ: Satisfaction and improvements in peritoneal dialysis outcomes associated with telehealth. Appl Clin Inform 2017; 8: 214–225.
24.
Salsberg E, Masselink L, Wu X: The US nephrology workforce: developments and trends. (https://www.asn-online.org/education/training/workforce/Nephrology_Workforce_Study_Report_2014.pdf) 2014; 1–22.
25.
United States Renal Data System: Incidence, prevalence, patient characteristics and treatment modalities (https://www.usrds.org/2015/download/vol2_01_IncidenceandPrevalence_15.pdf), 2013.
Published by S. Karger AG, Basel.
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.